24 results on '"Corwin, Claudia"'
Search Results
2. Incorporating Surgical Ergonomics Education into Surgical Residency Curriculum
3. Interstitial pulmonary disease and aluminum trihydrate exposure: A single case report and detailed workplace analysis
4. The case for improved transparency of disability insurance and workers' compensation claims data to study work-related injuries among surgeons
5. Management of the Contaminated Operation
6. Pneumoperitoneum
7. Vaccination Is Important to Protect Migrant Communities But Should Be Part of a Multifaceted Approach
8. Innovative Cohort Process to Minimize COVID-19 Infection for Migrant Farmworkers During Travel to Iowa
9. FDA Full Approval for COVID-19 Vaccine Increases the Call for Mandates
10. A Mobile Primary Care Clinic Mitigates an Early COVID-19 Outbreak Among Migrant Farmworkers in Iowa
11. Emergency Use Authorization of COVID-19 Vaccine: Implications for Worker Communities
12. Sudden Hearing Loss Associated with Tacrolimus in a Kidney-Pancreas Allograft Recipient
13. The efficacy of cytomegalovirus hyperimmune globulin in prevention of cytomegalovirus disease among transplant allograft recipients at high risk for primary infection.: 176.
14. Hearing loss with neurologic symptoms associated with high blood levels of tacrolimus in a kidney and pancreas transplant patient.: 2.
15. Adrenal Insufficiency
16. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years
17. RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1
18. RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2
19. CIRCADIAN VARIATION OF TACROLIMUS DISPOSITION IN LIVER ALLOGRAFT RECIPIENTS1
20. Cytomegalovirus prophylaxis in renal transplantation
21. RANDOMIZED TRIAL OF TACROLIMUS PLUS MYCOPHENOLATE MOFETIL OR AZATHIOPRINE VERSUS CYCLOSPORINE ORAL SOLUTION (MODIFIED) PLUS MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION: RESULTS AT 2 YEARS1.
22. RANDOMIZED TRIAL OF TACROLIMUS (PROGRAF) IN COMBINATION WITH AZATHIOPRINE OR MYCHOPHENOLATE MOFETIL VERSUS CYCLOSPORINE (NEORAL) WITH MYCOPHENOLATE MOFETIL AFTER CADAVERIC KIDNEY TRANSPLANTATION1, 2.
23. Randomized trial of tacrolimus mycophenolate mofetil or azathioprine versus cyclosporine mycophenolate mofetil after cadaveric kidney transplantation results at three years
24. CIRCADIAN VARIATION OF TACROLIMUS DISPOSITION IN LIVER ALLOGRAFT RECIPIENTS1.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.